Sotio

Czechia
Staňkov, Plzeň Region, Czechia, 170 00

Company profile

Sotio company profile

Sotio is an international biotechnology company leading the efforts of PPF Group to build a diverse biotechnology portfolio through its own research & development, collaborations, in-licensing, investments, mergers, and acquisitions. The company is developing new medical therapies, focusing on the treatment of cancer and autoimmune diseases. The most advanced project is the SOTIO proprietary platform of active cellular immunotherapy (ACI) based on dendritic cells.

Business identity

Contact email
[email protected]
Phone number
420 224 175 111
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Founded
2010-01-01, Year

Headquarters

Postal code
170 00
Country code
CZ
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$316.9M
Last funding
Series Unknown / $316.6M / 2021-12-02
Last equity funding
Series Unknown / $316.6M
Investors
1
Lead investors
1
Founders
1
Articles
32

Founders and investors

Founders

Radek Spisek

Lead investors

PPF Group

Investors

PPF Group